To address such a knowledge gap, this study assessed the effect of exogenous Ang II on SARS-CoV-2-specific T-cells response in peripheral blood mononuclear cells (PBMCs) obtained from recovered COVID-19 patients and stimulated with a SARS-CoV-2 peptide pool. Here, AGT is linked to COVID-19.